US 7285556
Thienopyrimidine-based inhibitors of the src family
granted A61KA61K31/519A61P
Quick answer
US patent 7285556 (Thienopyrimidine-based inhibitors of the src family) held by The Board of Regents of the University of Texas System expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/519, A61P, A61P19/10, A61P25/00